You are here

Home » CERID Bibliography

CERID Bibliography

Export 35 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Animals and Author is Brayton, Kelly A  [Clear All Filters]
Journal Article
Macmillan H, Brayton KA, Palmer GH, McGuire TC, Munske G, Siems WF, Brown WC. Analysis of the Anaplasma marginale major surface protein 1 complex protein composition by tandem mass spectrometry. J Bacteriol. 2006 ;188(13):4983-91.
Han S, Norimine J, Brayton KA, Palmer GH, Scoles GA, Brown WC. Anaplasma marginale infection with persistent high-load bacteremia induces a dysfunctional memory CD4+ T lymphocyte response but sustained high IgG titers. Clin Vaccine Immunol. 2010 ;17(12):1881-90.
Agnes JT, Herndon D, Ueti MW, Ramabu SS, Evans M, Brayton KA, Palmer GH. Association of pathogen strain-specific gene transcription and transmission efficiency phenotype of Anaplasma marginale. Infect Immun. 2010 ;78(6):2446-53.
Brown WC, Palmer GH, Brayton KA, Meeus PFM, Barbet AF, Kegerreis KA, McGuire TC. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3. Infect Immun. 2004 ;72(6):3688-92.
Noh SM, Brayton KA, Brown WC, Norimine J, Munske GR, Davitt CM, Palmer GH. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun. 2008 ;76(5):2219-26.
Meeus PFM, Brayton KA, Palmer GH, Barbet AF. Conservation of a gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. Mol Microbiol. 2003 ;47(3):633-43.
Noh SM, Brayton KA, Knowles DP, Agnes JT, Dark MJ, Brown WC, Baszler TV, Palmer GH. Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect Immun. 2006 ;74(6):3471-9.
Rodríguez J-L, Palmer GH, Knowles DP, Brayton KA. Distinctly different msp2 pseudogene repertoires in Anaplasma marginale strains that are capable of superinfection. Gene. 2005 ;361:127-32.
Ueti MW, Tan Y, Broschat SL, Ortiz EJCastañe, Camacho-Nuez M, Mosqueda JJ, Scoles GA, Grimes M, Brayton KA, Palmer GH. Expansion of variant diversity associated with a high prevalence of pathogen strain superinfection under conditions of natural transmission. Infect Immun. 2012 ;80(7):2354-60.
Ramabu SS, Schneider DA, Brayton KA, Ueti MW, Graça T, Futse JE, Noh SM, Baszler TV, Palmer GH. Expression of Anaplasma marginale ankyrin repeat-containing proteins during infection of the mammalian host and tick vector. Infect Immun. 2011 ;79(7):2847-55.
Löhr CV, Brayton KA, Shkap V, Molad T, Barbet AF, Brown WC, Palmer GH. Expression of Anaplasma marginale major surface protein 2 operon-associated proteins during mammalian and arthropod infection. Infect Immun. 2002 ;70(11):6005-12.
Shkap V, Molad T, Brayton KA, Brown WC, Palmer GH. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates. Infect Immun. 2002 ;70(2):642-8.
Palmer GH, Brayton KA. Gene conversion is a convergent strategy for pathogen antigenic variation. Trends Parasitol. 2007 ;23(9):408-13.
Futse JE, Brayton KA, Nydam SD, Palmer GH. Generation of antigenic variants via gene conversion: Evidence for recombination fitness selection at the locus level in Anaplasma marginale. Infect Immun. 2009 ;77(8):3181-7.
Brayton KA, Palmer GH, Brown WC. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale. Expert Rev Vaccines. 2006 ;5(1):95-101.
Brown WC, Brayton KA, Styer CM, Palmer GH. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. J Immunol. 2003 ;170(7):3790-8.
Stich RW, Olah GA, Brayton KA, Brown WC, Fechheimer M, Green-Church K, Jittapalapong S, Kocan KM, McGuire TC, Rurangirwa FR, et al. Identification of a novel Anaplasma marginale appendage-associated protein that localizes with actin filaments during intraerythrocytic infection. Infect Immun. 2004 ;72(12):7257-64.
Agnes JT, Brayton KA, LaFollett M, Norimine J, Brown WC, Palmer GH. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine. Infect Immun. 2011 ;79(3):1311-8.
Ramabu SS, Ueti MW, Brayton KA, Baszler TV, Palmer GH. Identification of Anaplasma marginale proteins specifically upregulated during colonization of the tick vector. Infect Immun. 2010 ;78(7):3047-52.
Barbet AF, Agnes JT, Moreland AL, Lundgren AM, A Alleman R, Noh SM, Brayton KA, Munderloh UG, Palmer GH. Identification of functional promoters in the msp2 expression loci of Anaplasma marginale and Anaplasma phagocytophilum. Gene. 2005 ;353(1):89-97.
Herndon DR, Ueti MW, Reif KE, Noh SM, Brayton KA, Agnes JT, Palmer GH. Identification of multilocus genetic heterogeneity in Anaplasma marginale subsp. centrale and its restriction following tick-borne transmission. Infect Immun. 2013 ;81(5):1852-8.
Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J, Brown WC. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun. 2005 ;73(12):8109-18.
Noh SM, Zhuang Y, Futse JE, Brown WC, Brayton KA, Palmer GH. The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity. Vaccine. 2010 ;28(21):3741-7.
Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE, Brown WC. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect Immun. 2007 ;75(5):2333-42.
Galletti MFBM, Ueti MW, Knowles DP, Brayton KA, Palmer GH. Independence of Anaplasma marginale strains with high and low transmission efficiencies in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host. Infect Immun. 2009 ;77(4):1459-64.

Pages